Justin D. Gover - 02 Jan 2026 Form 4 Insider Report for Design Therapeutics, Inc. (DSGN)

Role
Director
Signature
/s/ Mustapha Parekh, Attorney-in-Fact
Issuer symbol
DSGN
Transactions as of
02 Jan 2026
Net transactions value
$0
Form type
4
Filing time
05 Jan 2026, 16:10:23 UTC
Previous filing
10 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gover Justin D. Director C/O DESIGN THERAPEUTICS, INC., 6005 HIDDEN VALLEY ROAD, SUITE 110, CARLSBAD /s/ Mustapha Parekh, Attorney-in-Fact 05 Jan 2026 0001754129

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DSGN Stock option (right to buy) Award $0 +45,000 $0.000000 45,000 02 Jan 2026 Common Stock 45,000 $9.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest in equal monthly installments over 36 months following September 9, 2025.